Craft

Revenio

Stock Price

€31.9

2024-10-29

Market Capitalization

€847.3 M

2024-10-29

Revenue

€109.7 M

FY, 2025

Revenio Summary

Company Summary

Overview
Revenio designs, manufactures, and sells medical instruments used for measuring intraocular pressure and bone density. The Company offers tonometers for the measuring, monitoring, and screening intraocular pressure as part of diagnosing glaucoma and devices for detecting and monitoring asthma, and osteoporosis. Revenio serves general practitioners, ophthalmologists, emergency clinics, nurses, surgeons, veterinarians, dermatologists, pediatricians, charities, opticians' practices, defense forces, research laboratories.
Type
Public
Status
Active
Founded
2001
HQ
Vantaa, FI | view all locations
Website
http://www.reveniogroup.fi/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Robin Pulkkinen

    Robin Pulkkinen, CFO

    LocationsView all

    1 location detected

    • Vantaa HQ

      Finland

      22 Äyritie

    Revenio Financials

    Summary Financials

    Revenue (Q1, 2026)
    €27.3M
    Gross profit (Q1, 2026)
    €18.7M
    Net income (Q1, 2026)
    €2.5M
    Cash (Q1, 2026)
    €21.4M
    EBIT (Q1, 2026)
    €2.4M
    Enterprise value
    $830.7M

    Footer menu